About the impact of water movement on the permeation behaviour of nanoparticles in mucus

https://doi.org/10.1016/j.ijpharm.2016.12.024Get rights and content

Abstract

The purpose of this study was to establish a method to evaluate the diffusion behaviour of nanoparticles (NP) in mucus taking also the water movement into account. For this purpose, NP based on different chitosan derivatives, either thiolated or not, and marked with fluorescein diacetate were prepared by ionotropic gelation with hyaluronan. NP size and polydispersity were in the respective intervals 363.5 ± 33.3–385.7 ± 36.5 nm, and 0.35 ± 0.11–0.39 ± 0.10. An in vitro study of water-assisted NP transport through mucus was realized by filling the barrel of a syringe kept in vertical position, tip down, with mucus. Then a bottom-to-surface PBS flow across the mucus layer was realized by connecting the tip of the syringe to the bottom of a vertical cylindrical vessel by a flexible tubing, filling the vessel with PBS, level with the surface of the mucus layer in the syringe, and dripping PBS into the vessel without causing any phase mixing. Although the mucoadhesive NP interact more strongly with the mucus, yet they are able to overcome this barrier with the aid of the water movement from lumen to epithelium. This new method promises to be more predictive of in vivo NP transport across the mucus than already reported methods, as it takes into account the water movement and regulates its contribution to the physiologic value.

Graphical abstract

  1. Download : Download high-res image (116KB)
  2. Download : Download full-size image

Method to evaluate the diffusion of NP in mucus taking the intestinal water movement into account.

Introduction

Mucoadhesive polymeric nanoparticulate systems (NP) have raised interest as vehicles for drug delivery by the oral route for their potential ability to improve the bioavailability of drugs with low mucosal permeability and/or poor chemical stability in the gastrointestinal environment (Dünnhaupt et al., 2011, Ponchel et al., 1997, Sakuma et al., 2002, Sarmento et al., 2007, Takeuchi et al., 2001). To be absorbed across the intestinal epithelium into the systemic circulation, however, the NP will have to cross the layer of stagnant mucus adjacent to the intestinal membrane. Mucus is a viscoelastic gel layer primarily composed of crosslinked and entangled mucin fibers, continuously secreted and renewed by goblet cells and submucosal glands. The viscoelastic properties of GI mucus are essential for its protective and lubricating properties. In this light, mucus represents a barrier that can affect the transit of most orally administered particles. This layer is also crossed by the electrolytes and water that are absorbed by it (Hastewell et al., 1991), thereby generating pores that can be travelled by NP. These are thus given the possibility to reach the intestinal epithelium and cross it by transcytosis. In this context the tendency of NP to adhere to the mucus gel plays an important role since on the one hand it opposes the physiologic transit of the delivery system through the GI tract away from the absorption site, thus favouring drug absorption, whereas, on the other hand, it hampers the water-driven transport of NP from luminal to epithelial side of the mucus layer, thus slowing down absorption (Grießinger et al., 2015). Indeed, Maisel et al. (2015) on the basis of their results obtained in vivo with mice, stated that water absorption by the intestine increases in the fed state, and non-mucoadhesive NP can take advantage of this, for advective transport and hence, efficient and uniform drug delivery. In contrast mucoadhesive NP stick to the outer layers of mucus and aggregate in clumps far from the epithelial surface. In the light of the above information, it could be hypothesized that the water movement in the intestinal mucus could influence the distribution of mucoadhesive NP in the GI tract. For this reason, the purpose of the present work has been to develop and evaluate a simple in vitro system allowing the investigation of the movement of NP, either mucoadhesive or not, across a layer of porcine mucus concurrently crossed by a flow of phosphate buffered saline pH 6.8, 0.13 M (isotonic) (PBS), that could be adjusted to the physiologic flux value calculated from literature data for the human intestine (Lennernäs et al., 1994).Water-soluble quaternary ammonium-chitosan conjugates were used to prepare the NP (Zambito et al., 2008). To differentiate between more and less mucoadhesive NP these were prepared from chitosan derivatives containing thiol groups on their chains (more mucoadhesive) or thiol-free ones (less mucoadhesive) (Zambito et al., 2013).

Section snippets

Materials

The following materials were used, along with other usual reagent grade solvents and chemicals: fluorescein diacetate (FDA), D-(+)-trehalose dehydrate, thioglycolic acid, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride, cellulose membrane tubing MW cut-off 12.5 kDa (all from Sigma); 2-diethylaminoethyl chloride hydrochloride (Fluka); hyaluronic acid (HA), MW 950 kDa (Contipro, Dolní Dobrouč, Czech Republic); chitosan minimum 90% deacetylated from shrimp shell (Ch) (Chitoclear FG90,

Characteristics of NP

The NP where designed according to reported formulations to yield nanosystems either mucoahesive or not (Zambito et al., 2008, Zambito et al., 2013). The NP size, polydispersity index, zeta potential and marker EE in NP are found in Table 1. The size and polydispersity index are not significantly different from each other and are comprised within the ranges accepted for pharmaceutical nanoparticulate systems (Jani et al., 1990). The zeta-potential values are positive, in agreement with the

Discussion

Recently some research groups have developed in vitro methods for the study of NP diffusion through the mucus based on diffusion chambers (Franz (Li et al., 2011, or Ussing type (Takatsuka et al., 2006, Zabaleta et al., 2012) or Transwell/Snapwell (Norris and Sinko, 1997)). These systems were modified in order to have the donor and acceptor compartments separated by the mucus layer which, unlike the epithelial tissue, needs to be inserted between two parallel membranes that constitute the

Conclusions

In this work a new in vitro method has been developed for the study of NP penetration from the luminal to the epithelial side of the stagnant mucus layer adjacent to the intestinal epithelium. This method, which can modulate and simulate the osmotically-driven water flux across such a layer as it occurs in vivo, confirms the results obtained with other methods, demonstrating that more mucoadhesive NP penetrate the stagnant mucus layer with more difficulty than less mucoadhesive ones. In

References (30)

Cited by (21)

  • Recent advances on drug delivery applications of mucopenetrative/mucoadhesive particles: A review

    2022, Journal of Drug Delivery Science and Technology
    Citation Excerpt :

    Furthermore, it could be hypothesized that the nanoparticles migrate through the pores in the mucus created by the absorption of the water and are absorbed by the transcytosis. Finally, the authors concluded that this method could be useful to more efficiently predict the in vivo absorption of the nanoparticles compared to existing methods [113]. Similarly, Piras and his team studied dexamethasone (DEX)-loaded cyclodextrin complex in solution (QA-Ch-MCD/DEX complex) and NPs purified by centrifugation.

  • Emerging technologies to increase gastrointestinal transit times of drug delivery systems

    2022, Journal of Controlled Release
    Citation Excerpt :

    As during the absorption of water from the intestine a constant flow of intestinal fluids towards the absorption membrane is provided, nanocarriers are driven by this flow across the mucus gel layer towards the epithelium. In comparison to the concentration gradient of nanocarriers on the mucosa this effect is a much stronger driving force for them to reach the epithelium [13]. Nanocarriers that have reached the firm mucus gel layer close to the epithelium remain consequently there for a prolonged time period until they diffuse either back out into the gastrointestinal fluid as the concentration gradient has turned or are eliminated by the mucus turn over.

  • Ex vivo intestinal perfusion model for investigating mucoadhesion of microcontainers

    2019, International Journal of Pharmaceutics
    Citation Excerpt :

    The flow rate was e.g. calculated in relation to the size ratio between a rat and pig intestine (Sinko et al., 1995). Fabiano et al. have developed another simple setup for testing mucoadhesion of nanoparticles with an applied water flow through a mucus layer (Fabiano et al., 2017). However, this setup is limited by the size of the drug delivery systems as larger microdevices, such as microcontainers, are less affected by the water flow through the mucus layer compared to nanoparticles.

  • Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems

    2019, European Journal of Pharmaceutical Sciences
    Citation Excerpt :

    Furthermore, via this method even the self-diffusion coefficient of the diffusing species in mucus can be determined rather than just the percentage of drug or carrier system having permeated the mucus layer in a certain time period in dependence on the applied concentration gradient. Furthermore, even the impact of water movement through the mucus, as it is the case in the intestine because of extensive water absorption, can be simulated (Fabiano et al., 2017). Microscopic techniques are also based on mucus diffusion studies allowing a more rapid determination of the diffusion coefficient (Henry et al., 1992).

View all citing articles on Scopus
View full text